Cargando…
Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth
Amino acid transporters alanine-serine-cysteine transporter 2 (ASCT2) and L-Type Amino Acid Transporter 1 (LAT1) are coordinately enhanced in human cancers where among other roles, they are thought to drive mechanistic target-of-rapamycin (mTOR) growth signaling. To assess ASCT2 and LAT1 as therapeu...
Autores principales: | Bothwell, Paige J., Kron, Clare D., Wittke, Evan F., Czerniak, Bradley N., Bode, Barrie P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073291/ https://www.ncbi.nlm.nih.gov/pubmed/30029480 http://dx.doi.org/10.3390/ijms19072093 |
Ejemplares similares
-
ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation
por: Lopes, Catarina, et al.
Publicado: (2021) -
LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
por: Dias, Francisca, et al.
Publicado: (2021) -
Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
por: Toyoda, M, et al.
Publicado: (2014) -
Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
por: Polet, Florence, et al.
Publicado: (2016) -
SLC transporters ASCT2, B(0)AT1‐like, y(+)LAT1, and LAT4‐like associate with methionine electrogenic and radio‐isotope flux kinetics in rainbow trout intestine
por: To, Van P. T. H., et al.
Publicado: (2019)